TherapeuticsmdTXMD
13F holders, Q2 2024 (June 30)38holders −5
3new positions
8sold out
1famous investor
$1.61avg. 13F price*
At the end of Q2 2024, 38 institutions reported holding Therapeuticsmd Inc. (TXMD) in their 13F filings, down 5 from Q1 2024. 3 opened new positions and 8 sold out. The largest holders were Rubric Capital Management LP ($1.9M), Clearline Capital LP ($1.0M) and Tejara Capital Ltd ($647K). One famous investor held it Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- Therapeuticsmd Inc.
- CUSIP
- 88338N206
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2024 → Q2 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 3 | $23K |
| Exits | 8 | $172K |
All 13F filers, Q1 2024 → Q2 2024: 129,740 shares bought and 98,079 shares sold, net +31,661 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 38 holders
| Rubric Capital Management LP | 0.05% | No change | 1,192,191 | $1.9M |
| Clearline Capital LP | 0.09% | Add +18.9% | 636,622 | $1.0M |
| Tejara Capital Ltd | 0.24% | No change | 401,937 | $647K |
| Vanguard Group Inc. | 0.00% | No change | 387,582 | $624K |
| ADAR1 Capital Management, LLC | 0.09% | Reduce -0.7% | 270,160 | $435K |
| Morgan Stanley | 0.00% | Reduce -0.1% | 131,601 | $212K |
| BlackRock Inc. | 0.00% | Reduce -7.8% | 125,152 | $201K |
| Geode Capital Management, LLC | 0.00% | Add +12.6% | 95,477 | $154K |
| Bridgeway Capital Management, LLC | 0.00% | Reduce -13.0% | 34,000 | $55K |
| State Street Corp. | 0.00% | No change | 30,100 | $48K |
| Ameriprise Financial Inc. | 0.00% | No change | 22,470 | $36K |
| Northern Trust Corp. | 0.00% | No change | 16,457 | $26K |
| Two Sigma Securities, LLC | 0.00% | New | 14,359 | $23K |
| J. Goldman & Co LP | 0.00% | No change | 13,562 | $22K |
| Gabelli Funds LLC | 0.00% | No change | 12,000 | $19K |
| UBS Group AG | 0.00% | Add +16.7% | 9,116 | $15K |
| FMR LLC | 0.00% | No change | 8,289 | $13K |
| Tower Research Capital LLC (TRC) | 0.00% | Add +115.9% | 3,534 | $6K |
| Citadel Advisors | 0.00% | Reduce -68.2% | 1,576 | $3K |
| National Bank of Canada | 0.00% | Reduce -15.3% | 610 | $1K |
| Bank of America Corp. | 0.00% | Add +21.8% | 487 | $784 |
| JPMorgan Chase & Co. | 0.00% | No change | 293 | $471 |
| US Bancorp \de | 0.00% | Reduce -40.0% | 246 | $396 |
| Wells Fargo & Company | 0.00% | Reduce -36.0% | 171 | $275 |
| Principal Securities, Inc. | 0.00% | No change | 126 | $203 |
| Rhumbline Advisers | 0.00% | Reduce -12.9% | 122 | $196 |
| Huntington National Bank | 0.00% | No change | 120 | $193 |
| IFP Advisors, Inc | 0.00% | Add +33.3% | 80 | $129 |
| Osaic Holdings, Inc. | 0.00% | Reduce -94.6% | 56 | $90 |
| Activest Wealth Management | 0.00% | New | 40 | $64 |
| Provenance Wealth Advisors, LLC | 0.00% | No change | 20 | $32 |
| Harbour Investments, Inc. | 0.00% | No change | 8 | $13 |
| Qube Research & Technologies Ltd | 0.00% | No change | 2 | $4 |
| Guardian Wealth Management, Inc. | 0.00% | No change | 2 | $3 |
| EverSource Wealth Advisors, LLC | 0.00% | No change | 1 | $2 |
| Aspire Private Capital, LLC | 0.00% | No change | 1 | $2 |
| Royal Bank of Canada | 0.00% | Reduce -54.7% | 234 | $0 |
| Tsfg, LLC | 0.00% | New | 64 | $0 |
"% of holder's portfolio" is TXMD's weight in each manager's 13F, not the share of Therapeuticsmd Inc. the manager owns.